BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33228555)

  • 1. Incidence of Huntington disease in a northeastern Spanish region: a 13-year retrospective study at tertiary care centre.
    Sienes Bailo P; Lahoz R; Sánchez Marín JP; Izquierdo Álvarez S
    BMC Med Genet; 2020 Nov; 21(1):233. PubMed ID: 33228555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.
    Chheda P; Chanekar M; Salunkhe Y; Dama T; Pais A; Pande S; Bendre R; Shah N
    Mol Diagn Ther; 2018 Jun; 22(3):353-359. PubMed ID: 29619771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.
    Zhao M; Lee CG; Law HY; Chong SS
    Neurodegener Dis; 2016; 16(5-6):348-51. PubMed ID: 27207688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new mutation for Huntington disease following maternal transmission of an intermediate allele.
    Semaka A; Kay C; Belfroid RD; Bijlsma EK; Losekoot M; van Langen IM; van Maarle MC; Oosterloo M; Hayden MR; van Belzen MJ
    Eur J Med Genet; 2015 Jan; 58(1):28-30. PubMed ID: 25464109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HTT CAG repeat expansion among healthy individuals and patients with chorea in Korea.
    Kim R; Seong MW; Oh B; Shin HS; Lee JS; Park S; Jang M; Jeon B; Kim HJ; Lee JY
    Parkinsonism Relat Disord; 2024 Jan; 118():105930. PubMed ID: 37992538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis and prevalence of Huntington disease in northwestern Iran.
    Shekari Khaniani M; Aob P; Ranjouri M; Mansoori Derakhsan S
    Turk J Med Sci; 2017 Dec; 47(6):1880-1884. PubMed ID: 29306253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.
    Ciosi M; Maxwell A; Cumming SA; Hensman Moss DJ; Alshammari AM; Flower MD; Durr A; Leavitt BR; Roos RAC; ; ; Holmans P; Jones L; Langbehn DR; Kwak S; Tabrizi SJ; Monckton DG
    EBioMedicine; 2019 Oct; 48():568-580. PubMed ID: 31607598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Triplet-Primed PCR Assay to Detect the Full Range of Trinucleotide CAG Repeats in the Huntingtin Gene (
    De Luca A; Morella A; Consoli F; Fanelli S; Thibert JR; Statt S; Latham GJ; Squitieri F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
    Apolinário TA; da Silva IDS; Agostinho LA; Paiva CLA
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1181. PubMed ID: 32067426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
    Kay C; Collins JA; Wright GEB; Baine F; Miedzybrodzka Z; Aminkeng F; Semaka AJ; McDonald C; Davidson M; Madore SJ; Gordon ES; Gerry NP; Cornejo-Olivas M; Squitieri F; Tishkoff S; Greenberg JL; Krause A; Hayden MR
    Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):346-357. PubMed ID: 29460498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington disease reduced penetrance alleles occur at high frequency in the general population.
    Kay C; Collins JA; Miedzybrodzka Z; Madore SJ; Gordon ES; Gerry N; Davidson M; Slama RA; Hayden MR
    Neurology; 2016 Jul; 87(3):282-8. PubMed ID: 27335115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of intermediary alleles in the HTT gene in Northern Sweden - The Swedish Huntingtin Alleles and Phenotype (SHAPE) study.
    Sundblom J; Niemelä V; Ghazarian M; Strand AS; Bergdahl IA; Jansson JH; Söderberg S; Stattin EL
    Sci Rep; 2020 Jun; 10(1):9853. PubMed ID: 32555394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing the pathological expansion in Huntington disease: de novo c.51C>G variant on the expanded allele causing intrafamilial allele dropout.
    Magri S; Nanetti L; Mongelli A; Rizzo E; Taroni F; Mariotti C; Gellera C
    Am J Med Genet A; 2021 Feb; 185(2):397-400. PubMed ID: 33247537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
    Savitt D; Jankovic J
    J Neurol Sci; 2019 Jul; 402():57-61. PubMed ID: 31103960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
    Wright GEB; Collins JA; Kay C; McDonald C; Dolzhenko E; Xia Q; Bečanović K; Drögemöller BI; Semaka A; Nguyen CM; Trost B; Richards F; Bijlsma EK; Squitieri F; Ross CJD; Scherer SW; Eberle MA; Yuen RKC; Hayden MR
    Am J Hum Genet; 2019 Jun; 104(6):1116-1126. PubMed ID: 31104771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntingtin gene CAG repeat size affects autism risk: Family-based and case-control association study.
    Piras IS; Picinelli C; Iennaco R; Baccarin M; Castronovo P; Tomaiuolo P; Cucinotta F; Ricciardello A; Turriziani L; Nanetti L; Mariotti C; Gellera C; Lintas C; Sacco R; Zuccato C; Cattaneo E; Persico AM
    Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):341-351. PubMed ID: 32652810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
    Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
    J Huntingtons Dis; 2015; 4(2):141-8. PubMed ID: 26397895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.
    Williams LC; Hegde MR; Nagappan R; Faull RL; Giles J; Winship I; Snow K; Love DR
    Genet Test; 2000; 4(1):55-60. PubMed ID: 10794362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease.
    Semaka A; Kay C; Doty C; Collins JA; Bijlsma EK; Richards F; Goldberg YP; Hayden MR
    J Med Genet; 2013 Oct; 50(10):696-703. PubMed ID: 23896435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.